awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28084683-73603565-8D91-403D-9A8E-F6336C240CB8
Q28084683-73603565-8D91-403D-9A8E-F6336C240CB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084683-73603565-8D91-403D-9A8E-F6336C240CB8
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors
P2860
Q28084683-73603565-8D91-403D-9A8E-F6336C240CB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084683-73603565-8D91-403D-9A8E-F6336C240CB8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ba6302b47276c35413cfc4c21c4fa5e72e93184
P2860
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.